Momentum Bioscience Patents – Insights & Stats (Updated 2023)

Momentum Bioscience has a total of 84 patents globally, out of which 39 have been granted. Of these 84 patents, more than 61% patents are active. The United States of America is where Momentum Bioscience has filed the maximum number of patents, followed by United Kingdom and Europe. Parallelly, United Kingdom seems to be the main focused R&D centre and also is the origin country of Momentum Bioscience.

Momentum Bioscience was founded in 2005. Momentum Bioscience operates as a biotechnology company. The company develops a method that can to identify infections in sterile bodily fluids like blood.

Do read about some of the most popular patents of Momentum Bioscience which have been covered by us in this article and also you can find Momentum Bioscience patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Momentum Bioscience patent portfolio.

How many patents does Momentum Bioscience have?

Momentum Bioscience has a total of 84 patents globally. These patents belong to 23 unique patent families. Out of 84 patents, 52 patents are active.

How Many Patents did Momentum Bioscience File Every Year?

Momentum Bioscience Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantMomentum Bioscience Applications FiledMomentum Bioscience Patents Granted

How many Momentum Bioscience patents are Alive/Dead?

Worldwide Patents

Momentum Bioscience Patent Portfolio

How Many Patents did Momentum Bioscience File in Different Countries?

Momentum Bioscience Worldwide Patent Filing

Countries in which Momentum Bioscience Filed Patents

United States Of America13
United Kingdom10
Korea (South)2

Where are Research Centers of Momentum Bioscience Patents Located?

R&D Centres of Momentum Bioscience

What Percentage of Momentum Bioscience US Patent Applications Were Granted?

Momentum Bioscience (Excluding its subsidiaries) has filed 11 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 6 have been granted leading to a grant rate of 66.67%.

Below are the key stats of Momentum Bioscience patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Momentum Bioscience?

Law FirmTotal ApplicationsSuccess Rate
Quarles & Brady Llp5100.00%
Andrus IP Law Llp333.33%
Hunton Andrews Kurth Llp2100.00%
Wilkinson Law Llc10.00%

What are Momentum Bioscience key innovation segments?

What Technologies are Covered by Momentum Bioscience?

The chart below distributes patents filed by Momentum Bioscience in different countries on the basis of the technology protected in patents. It also represents the markets where Momentum Bioscience thinks it’s important to protect particular technology inventions.

R&D Focus: How has Momentum Bioscience search focus changed over the years?


Interested in knowing about the areas of innovation that are being protected by Momentum Bioscience?

Related Articles

Arashi Vision Patents – Insights & Stats (Updated 2024)

Arashi Vision has a total of 1257 patents globally, out of which 751 have been granted. Of these 1257 patents, more than 87% patents are active. China is where Arashi Vision has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, China seems

Read More »

Terecircuits Patents – Insights & Stats (Updated 2024)

Terecircuits has a total of 43 patents globally, out of which 22 have been granted. Of these 43 patents, more than 37% patents are active. United States of America is where Terecircuits has filed the maximum number of patents, followed by Europe (EPO) and Taiwan. Parallelly, United States of America

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.